Bull of the Day: Penumbra (PEN)

06:46am, Friday, 22'nd Sep 2023
Penumbra ( PEN ) is the $10 billion innovator of neurovascular treatments for stroke using catheter aspiration technologies. After a solid beat-and-raise Q2 reported in early August, upward estimate r
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Strategic Education (STRA) and Huron (HURN) are poised to gain.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Investors are upbeat about Penumbra (PEN) on Strong uptake following the launch of Lightning Flash, which accelerated top-line growth.
Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.
Penumbra's (PEN) U.S. thrombectomy records 50% year-over-year growth, while the international Vascular business sees relatively flat sales in the second quarter.
Penumbra, Inc. (NYSE:PEN ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Jee Hamlyn-Harris - IR Adam Elsesser - Chairman and CEO Maggie Yuen - CFO Jason Mills - EVP,
Penumbra (PEN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.01 per share a year ago.
Penumbra's (PEN) ability to improve net gross margins and EPS amid ongoing inflationary pressure and supply-chain headwinds buoy optimism.
ALAMEDA, Calif. , July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after market clo
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Trip.com Group (TCOM), Transportadora (TGS) and Vipshop Holdings (VIPS) are poised to gain.

Penumbra: Impressive, But Running A Bit Hot

02:10pm, Thursday, 22'nd Jun 2023
Penumbra, Inc. has seen continued, steady, and impressive top-line sales growth over the past decade. This sales growth is now resulting in modest profits on the bottom line as well. I like the busine
Penumbra, Inc. continues pushing higher, and I have revised my price target of $490. The company's fundamental drivers, sentimental factors, and valuation all indicate further value could be obtained.
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Lamb Weston (LW), Transportadora (TGS) and Vipshop Holdings (VIPS) are poised to gain.
Penumbra (PEN) launches Lightning Bolt 7, a new technology that can remove blood clots faster and more efficiently with modulated aspiration.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE